00:01
The other concept to pay attention to is the
autonomic nervous system and the sympathetic
and parasympathetic, because these are going
to affect breathing and can
help or hurt breathing.
00:13
When you think about the sympathetics, those
are thoracic segments.
00:16
T1 through T5, they innervate the lungs.
00:20
They're going to cause bronchodilatio,n and
they're going to affect the mucous
secretions, both the amount and the
thickness.
00:26
So you want to make sure you have optimal
viscosity so that it can bay the lungs and
enhance oxygen exchange, but not block
oxygen exchange.
00:35
The autonomic nervous system is critical for
monitoring
what's going on with breathing.
00:41
You have nociceptors which tell you about
the pressure and what's happening within the
lungs, and they feed back into the autonomic
nervous system through the upper
thoracic communication pathways.
00:54
And again, a lot of the information is
coming from the upper thoracic region.
00:58
The vagus nerve is what's going to moderate,
moderate, the parasympathetic innervation of
the lungs. And that's what's going to cause
bronchoconstriction and
increase mucous production in the lungs.
01:11
And the nociceptors from the smaller airways
which go through the vagus are going to
moderate what's going on in asthma and small
airway disease and let the body know what
needs to be done. The vagus has been shown
to reflex with the upper,
upper cervical spine and that pathway is
through C
two and the sensory ganglion of the vagus
are found at the OA and jugular
foramen. When you treat segmental
dysfunction, it's important to focus on those
areas because that will enhance physiologic
function and prevent a spiraling down and
deterioration in the area.
01:47
The other goal is to decrease the use of
inhalers and most studies of OMM and
pulmonary disease use that as a secondary
endpoint, which is hospitalizations and
the medications used.
01:59
Lymphatics also need to be taken into
consideration as a secondary
system for bathing the lung and returning
fluids to the lung.
02:09
And in asthma and pneumonia.
02:11
You may want to check the lymphatic return
and understand what's going on with the
pulmonary lymphatics, both in the chest wall
cavity and making sure that you address that
issue as well because pulmonary lymphatics
dump into the vasculature but
have their own system for distribution.
02:28
The airways are drained by the lymphatics,
but they also have blood supply as well.
02:33
And this is moderated by mucociliary
mechanisms.
02:38
The mucociliary mechanisms doesn't extend to
the terminal bronchioles of the or the
alveoli. So the drainage is going to be a
separate system and discrete.
02:48
Paying attention to pulmonary lymphatics,
particularly in asthma and pneumonia.
02:52
We'll help you understand what needs to be,
what needs to be treated and how drainage
is occurring through the lymphatics.
02:59
So the pulmonary lymph is enhanced with
respiration, with excursion.
03:04
You're going to have return of the lymph and
dumping of the lymph into the vascular
system. So pay attention to the respiratory
excursion and make sure that
adequate return is being allowed.
03:15
When you treat the pulmonary patient, make
sure you pay attention to positions of
comfort, examine them for paradoxical versus
fluid
motion. Do what you can to improve the
efficiency of the respiratory musculature so
that they can breathe comfortably, reduce
segmental facilitation as
a way of allowing communication to occur and
the body to heal itself and do what you can
to improve lymphatic drainage.
03:40
I pay a lot of attention to the ribs, making
sure that you do have good pump handle and
bucket handle motion and secondarily to the
vertebrae where the ribs
attach because that's going to eventually
become a problem as well.
03:54
So that's my talk on the respiratory
effects, on the musculoskeletal system,
and the role of OMM and pulmonary
conditions.
04:03
Thank you.